Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|January 4, 2015
Structural definitions of Jumonji family demethylase selectivityEwa S Pilka, Tim James, Joanna Hergovich Lisztwan
Trends in Pharmacological Sciences|April 19, 2021
Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19Tahsin F Kellici, Ewa S Pilka, Michael J Bodkin
Drug Discovery Today|December 1, 2020
Small-molecule modulators of serine protease inhibitor proteins (serpins)Tahsin F Kellici, Ewa S Pilka, Michael J Bodkin
Biochemical and Biophysical Research Communications|February 28, 2012
Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor developmentEwa S Pilka, Grazyna Kochan, Udo Oppermann, et al.
Journal of Molecular Biology|April 7, 2009
Structural snapshots for the conformation-dependent catalysis by human medium-chain acyl-coenzyme A synthetase ACSM2AGrazyna Kochan, Ewa S Pilka, Frank von Delft, et al.
Journal of Biomolecular NMR|March 18, 2005
Probing protein-peptide binding surfaces using charged stable free radicals and transverse paramagnetic relaxation enhancement (PRE)Michaël L Deschamps, Ewa S Pilka, Jennifer R Potts, et al.
Bioorganic & Medicinal Chemistry|December 23, 2008
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenoneTobias J Zimmermann, Frank H Niesen, Ewa S Pilka, et al.
Chemico-Biological Interactions|December 9, 2008
Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesisYasser El-Hawari, Angelo D Favia, Ewa S Pilka, et al.
The Journal of Biological Chemistry|July 13, 2004
High affinity streptococcal binding to human fibronectin requires specific recognition of sequential F1 modulesUlrich Schwarz-Linek, Ewa S Pilka, Andrew R Pickford, et al.
Pageof 3